Lupus Landmark Study: A Prospective Registry and Biorepository
Lupus Nephritis | Systemic Lupus Erythematosus (SLE) | Neuropsychiatric Systemic Lupus ErythematosusThe purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
18 and up
Critères de participation
Inclusion Criteria:
* Able to understand and comply with study procedures and voluntarily sign a written informed consent document
* Age 18 years or older at the time of enrollment
* Fulfill criteria for SLE based on one or more of the following classifications systems:
Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment.
Exclusion Criteria:
* Not able to obtain consent
* Not able to meet protocol visit requirements
* Pregnant at the time of enrollment
Lieu de l'étude
CHU de Québec - Université Laval
CHU de Québec - Université LavalQuebec City, Quebec
Canada
Contactez l'équipe d'étude
University Health Network/Toronto Western Hospital
University Health Network/Toronto Western HospitalToronto, Ontario
Canada
Contactez l'équipe d'étude
University of Calgary
University of CalgaryCalgary, Alberta
Canada
Contactez l'équipe d'étude
University of Manitoba
University of ManitobaWinnipeg, Manitoba
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- Lupus Research Alliance
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT05934149